
C-CAMP and Indegene tie up to help early-stage life sciences startups
The Hindu
The multi-year agreement will see Indegene bring in financial assistance, mentorship via highly skilled and specialised experts, and a digital service suite, supporting C-CAMP’s efforts in nurturing at least 5-7 early-stage deep-science startups with a 360-degree ecosystem.
Centre for Cellular and Molecular Platforms (C-CAMP) and Indegene, a digital-first life sciences commercialisation company, have joined hands to help early-stage life sciences start-ups accelerate technology innovation, product development, and go-to-market.
The multi-year agreement will see Indegene bring in financial assistance, mentorship via highly skilled and specialised experts, and a digital service suite, supporting C-CAMP’s efforts in nurturing at least 5-7 early-stage deep-science startups with a 360-degree ecosystem. This initiative aligns with Indegene’s philosophy of enabling future-ready healthcare globally. The goal of the partnership is to leverage C-CAMP’s incubation programme to strengthen the life sciences innovation ecosystem in India and help bring new drugs and therapies to market faster.

Scaling Artificial Intelligence(AI) at the speed at which consultants project is not possible by the laws of physics and may not be environmentally sustainable, said Tanvir Khan, who is the Executive Vice President and Chief Operating Officer of NTT DATA North America, part of the Japanese technology services and data centre company NTT Data, in an interview with The Hindu.












